Results 71 to 80 of about 17,376 (176)

Autophagy and Autosomal Dominant Polycystic Kidney Disease

Turkish Journal of Nephrology, 2023
Özgür Akın Oto, Charles L. Edelstein
doaj   +1 more source

Genetics of Autosomal Dominant Polycystic Kidney Disease

Turkish Journal of Nephrology, 2019
-
Kıvanç ÇEFLE
doaj  

Treatment of Autosomal-Dominant Polycystic Kidney Disease

American Journal of Kidney Diseases
Autosomal-dominant polycystic kidney disease (ADPKD) is a chronic systemic disease that affects all races and ethnicities. It is the fourth leading cause of end-stage kidney disease, and it has a heterogenous phenotype ranging from mild to severe disease.
Sara S, Jdiaa, Reem A, Mustafa, Alan S L, Yu   +2 more
openaire   +2 more sources

Linezolid as a potential alternative to glycopeptide in treating suspected cyst infection in a hemodialysis patient with autosomal-dominant polycystic kidney disease: A case report

SAGE Open Medical Case Reports
Autosomal-dominant polycystic kidney disease is a clinically significant disorder associated with progressive renal impairment. In these patients, cyst infection is an important but variably occurring complication, and optimal antibiotic selection ...
Takahito Inagaki, Mai Otsu, Akitoshi Takuma, Kenji Momo   +3 more
doaj   +1 more source

Activation of PIEZO1 Attenuates Kidney Cystogenesis In Vitro and Ex Vivo

Kidney360
Key Points. PIEZO1 activation reduces cystogenesis: Yoda1 activates PIEZO1, raising calcium and lowering cAMP, reducing cyst growth in autosomal dominant polycystic kidney disease models.
Qingfeng Fan, Mohamad Hadla, Zack Peterson, Grace Nelson, Hong Ye, Xiaofang Wang, Jean Marc Mardirossian, Peter C. Harris, Seth L. Alper, Y.S. Prakash, Arthur Beyder, Vicente E. Torres, Fouad T. Chebib   +12 more
doaj   +1 more source

Renal Transplantation in Autosomal Dominant Polycystic Kidney Disease [PDF]

European Medical Journal Nephrology, 2015
Autosomal dominant polycystic kidney disease (ADPKD) affects approximately 1 in 1,000 people in the general population. The natural history of ADPKD includes the progression of chronic kidney disease to end-stage renal disease (ESRD) in a large ...
Andrzej Kulesza, Longin Niemczyk, Mariusz Niemczyk   +2 more
doaj  

HYPERTENSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

Turkish Journal of Nephrology, 2019
-
Züleyha AKKAN, Tevfık ECDER
doaj  

Epigenetics and autosomal dominant polycystic kidney disease

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
The roles of epigenetic modulation of gene expression and protein functions in autosomal dominant polycystic kidney disease (ADPKD) have recently become the focus of scientific investigation. Evidence generated to date indicates that one of the epigenetic modifiers, histone deacetylases (HDACs), are important regulators of ADPKD.
openaire   +2 more sources

Hereditary Renal Cystic Diseases

Turkish Journal of Nephrology, 2019
Polycystic kidney disease is one of the most common reasons of end stage renal failure. Polycystic kidney disease may result from many etiological factors, but frequently arises hereditarily.
Alper UZAK, M. Deniz AYLI
doaj  

Immune microenvironment in autosomal dominant polycystic kidney disease

Genes and Diseases
Autosomal dominant polycystic kidney disease (ADPKD) is a common hereditary renal disorder characterized by the progressive development of fluid-filled cysts within the kidneys, leading to renal dysfunction and potentially life-threatening complications.
Cheng Xue, Xinming Li, Chenchen Zhou, Changlin Mei, Zhiguo Mao   +4 more
doaj   +1 more source